Skip to main content
Journal cover image

Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years

Publication ,  Journal Article
Adam, MA; Pura, J; Goffredo, P; Dinan, MA; Hyslop, T; Reed, SD; Scheri, RP; Roman, SA; Sosa, JA
Published in: Journal of Clinical Endocrinology and Metabolism
2015

© 2015 by the Endocrine Society.Context: Papillary thyroid cancer (PTC) patients <45 years old are considered to have an excellent prognosis; however, current guidelines recommend total thyroidectomy for PTC tumors 1.0 cm, regardless of age. Objective: Our objective was to examine the impact of extent of surgery on overall survival (OS) in patients <45 years old with stage I PTC of 1.1 to 4.0 cm. Design, Setting, and Patients: Adult patients <45 years of age undergoing surgery for stage I PTC were identified from the National Cancer Data Base (NCDB, 1998-2006) and the Surveillance, Epidemiology, and End Results dataset (SEER, 1988-2006). Main Outcome Measure: Multivariable modeling was used to compare OS for patients undergoing total thyroidectomy vs lobectomy. Results: In total, 29 522 patients in NCDB (3151 lobectomy, 26 371 total thyroidectomy) and 13 510 in SEER (1379 lobectomy, 12 131 total thyroidectomy) were included. Compared with patients undergoing lobectomy, patients having total thyroidectomy more often had extrathyroidal and lymph node disease. At 14 years, unadjusted OS was equivalent between total thyroidectomy and lobectomy in both databases. After adjustment, OS was similar for total thyroidectomy compared with lobectomy across all patients with tumors of 1.1 to 4.0 cm (NCDB: hazard ratio = 1.45 [confidence interval = 0.88-2.51], P = 0.19; SEER: 0.95 (0.70 -1.29), P = 0.75) and when stratified by tumor size: 1.1 to 2.0 cm (NCDB: 1.12 [0.50 -2.51], P=0.78; SEER: 0.95 [0.56 -1.62], P=0.86) and 2.1 to 4.0 cm (NCDB: 1.93 [0.88-4.23], P = 0.10; SEER: 0.94 [0.60 -1.49], P = 0.80). Conclusions: After adjusting for patient and clinical characteristics, total thyroidectomy compared with thyroid lobectomy was not associated with improved survival for patients <45 years of age with stage I PTC of 1.1 to 4.0 cm. Additional clinical and pathologic factors should be considered when choosing extent of resection.

Duke Scholars

Published In

Journal of Clinical Endocrinology and Metabolism

DOI

ISSN

0021-972X

Publication Date

2015

Volume

100

Issue

1

Start / End Page

115 / 121

Related Subject Headings

  • Endocrinology & Metabolism
  • 3202 Clinical sciences
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Adam, M. A., Pura, J., Goffredo, P., Dinan, M. A., Hyslop, T., Reed, S. D., … Sosa, J. A. (2015). Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years. Journal of Clinical Endocrinology and Metabolism, 100(1), 115–121. https://doi.org/10.1210/jc.20143039
Adam, M. A., J. Pura, P. Goffredo, M. A. Dinan, T. Hyslop, S. D. Reed, R. P. Scheri, S. A. Roman, and J. A. Sosa. “Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years.” Journal of Clinical Endocrinology and Metabolism 100, no. 1 (2015): 115–21. https://doi.org/10.1210/jc.20143039.
Adam MA, Pura J, Goffredo P, Dinan MA, Hyslop T, Reed SD, et al. Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years. Journal of Clinical Endocrinology and Metabolism. 2015;100(1):115–21.
Adam, M. A., et al. “Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years.” Journal of Clinical Endocrinology and Metabolism, vol. 100, no. 1, 2015, pp. 115–21. Scival, doi:10.1210/jc.20143039.
Adam MA, Pura J, Goffredo P, Dinan MA, Hyslop T, Reed SD, Scheri RP, Roman SA, Sosa JA. Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years. Journal of Clinical Endocrinology and Metabolism. 2015;100(1):115–121.
Journal cover image

Published In

Journal of Clinical Endocrinology and Metabolism

DOI

ISSN

0021-972X

Publication Date

2015

Volume

100

Issue

1

Start / End Page

115 / 121

Related Subject Headings

  • Endocrinology & Metabolism
  • 3202 Clinical sciences
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences